These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38048777)

  • 21. Liver X receptor β and peroxisome proliferator-activated receptor δ regulate cholesterol transport in murine cholangiocytes.
    Xia X; Jung D; Webb P; Zhang A; Zhang B; Li L; Ayers SD; Gabbi C; Ueno Y; Gustafsson JÅ; Alpini G; Moore DD; Lesage GD
    Hepatology; 2012 Dec; 56(6):2288-96. PubMed ID: 22729460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of bile acid and cholesterol metabolism by PPARs.
    Li T; Chiang JY
    PPAR Res; 2009; 2009():501739. PubMed ID: 19636418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.
    Plutzky J
    Curr Atheroscler Rep; 2000 Jul; 2(4):327-35. PubMed ID: 11122762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile acid metabolism and signaling.
    Chiang JY
    Compr Physiol; 2013 Jul; 3(3):1191-212. PubMed ID: 23897684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
    Blaschke F; Takata Y; Caglayan E; Law RE; Hsueh WA
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):28-40. PubMed ID: 16239592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome.
    Guan Y
    J Am Soc Nephrol; 2004 Nov; 15(11):2801-15. PubMed ID: 15504933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Policosanol alleviates hepatic lipid accumulation by regulating bile acids metabolism in C57BL6/mice through AMPK-FXR-TGR5 cross-talk.
    Zhai Z; Niu KM; Liu H; Lin C; Tu Y; Liu Y; Cai L; Ouyang K; Liu J
    J Food Sci; 2021 Dec; 86(12):5466-5478. PubMed ID: 34730235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis.
    Wang C; Shi Y; Wang X; Ma H; Liu Q; Gao Y; Niu J
    Front Immunol; 2022; 13():940688. PubMed ID: 35880178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
    Schoonjans K; Staels B; Auwerx J
    Biochim Biophys Acta; 1996 Jul; 1302(2):93-109. PubMed ID: 8695669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators?
    Beuers U; Kullak-Ublick GA; Pusl T; Rauws ER; Rust C
    Clin Rev Allergy Immunol; 2009 Feb; 36(1):52-61. PubMed ID: 18751930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear receptors in bile acid metabolism.
    Li T; Chiang JY
    Drug Metab Rev; 2013 Feb; 45(1):145-55. PubMed ID: 23330546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [FXR modulators and cholestatic diseases.].
    Alvaro D; Bragazzi MC; Venere R; Ridola L
    Recenti Prog Med; 2021 Feb; 112(2):124-127. PubMed ID: 33624625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics.
    Dixit G; Prabhu A
    Exp Mol Pathol; 2022 Feb; 124():104723. PubMed ID: 34822814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis.
    Li AC; Glass CK
    J Lipid Res; 2004 Dec; 45(12):2161-73. PubMed ID: 15489539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An overview on biological mechanisms of PPARs.
    Kota BP; Huang TH; Roufogalis BD
    Pharmacol Res; 2005 Feb; 51(2):85-94. PubMed ID: 15629253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice.
    Torra IP; Chinetti G; Duval C; Fruchart JC; Staels B
    Curr Opin Lipidol; 2001 Jun; 12(3):245-54. PubMed ID: 11353326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The gene encoding the human ileal bile acid-binding protein (I-BABP) is regulated by peroxisome proliferator-activated receptors.
    Landrier JF; Thomas C; Grober J; Zaghini I; Petit V; Poirier H; Niot I; Besnard P
    Biochim Biophys Acta; 2005 Jun; 1735(1):41-9. PubMed ID: 15936983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic role of bile acids and nuclear receptor agonists in fibrosing cholangiopathies.
    Trauner M; Halilbasic E; Kazemi-Shirazi L; Kienbacher C; Staufer K; Traussnigg S; Hofer H
    Dig Dis; 2014; 32(5):631-6. PubMed ID: 25034298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.